Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Treasury Shares (2016 - 2025)

Cytosorbents (CTSO) has disclosed Treasury Shares for 10 consecutive years, with $810300.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Treasury Shares rose 26.35% year-over-year to $810300.0, compared with a TTM value of $810300.0 through Sep 2025, up 26.35%, and an annual FY2024 reading of $641335.0, up 48.97% over the prior year.
  • Treasury Shares was $810300.0 for Q3 2025 at Cytosorbents, up from $547335.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $2.8 million in Q1 2025 and bottomed at $125340.0 in Q2 2022.
  • Average Treasury Shares over 5 years is $537795.5, with a median of $344247.0 recorded in 2021.
  • The sharpest move saw Treasury Shares crashed 63.59% in 2022, then skyrocketed 505.31% in 2025.
  • Year by year, Treasury Shares stood at $304962.0 in 2021, then grew by 2.34% to $312092.0 in 2022, then soared by 37.94% to $430505.0 in 2023, then skyrocketed by 48.97% to $641335.0 in 2024, then grew by 26.35% to $810300.0 in 2025.
  • Business Quant data shows Treasury Shares for CTSO at $810300.0 in Q3 2025, $547335.0 in Q2 2025, and $2.8 million in Q1 2025.